The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis.

Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis. J Immunol Res (2015) 0.75

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum (1986) 29.12

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (2010) 18.82

Polymyositis and dermatomyositis (first of two parts). N Engl J Med (1975) 18.52

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66

Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum (1977) 8.55

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum (1991) 7.94

Polymyositis and dermatomyositis (second of two parts). N Engl J Med (1975) 7.26

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med (2007) 6.98

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97

Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD): pseudogout. Radiology (1977) 2.39

Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol (1989) 1.99

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum (2007) 1.93

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum (2008) 1.68

A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum (1980) 1.10

Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol Int (2008) 1.03

Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev (2012) 0.98

Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis (2011) 0.96

Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis (2009) 0.90

Further observations on the arthropathy of calcium pyrophosphate crystal deposition disease. Radiology (1981) 0.89

Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay. Arthritis Res Ther (2010) 0.79

Evaluation of a pilot program for rheumatic disability in an urban community. Arthritis Rheum (1981) 0.75

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev (2013) 1.62

Reply to the letter regarding "Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis". J Gastroenterol (2013) 1.39

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Ann Rheum Dis (2010) 1.32

Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy. Int J Rheum Dis (2013) 0.84

Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis. J Gastroenterol (2012) 0.83

Antimalarial-induced maculopathy: accuracy of Amsler grid as a diagnostic tool and risk factors. J Med Assoc Thai (2012) 0.76

Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis. Int J Rheum Dis (2014) 0.75

Prevalence and risk factors of symptomatic hyperuricemia; quality of care of patients with hyperuricemia in a university hospital. J Med Assoc Thai (2013) 0.75

Validation of the Thai version of the questionnaire for identifying subjects with potential rheumatic diseases. J Med Assoc Thai (2014) 0.75

Clinical manifestation, diagnosis, management, and treatment outcome of pericarditis in patients with systemic lupus erythematosus. J Med Assoc Thai (2014) 0.75

Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus. J Clin Rheumatol (2014) 0.75